Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients

Else A. Aalbersberg; Daphne M.V. Huizing; Iris Walraven; Berlinda J. de Wit-van der Veen; Harshad R. Kulkarni; Aviral Singh; Marcel P.M. Stokkel; Richard P. Baum

doi:10.2967/jnumed.118.224386

Research ArticleTheranostics

Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients

Else A. Aalbersberg, Daphne M.V. Huizing, Iris Walraven, Berlinda J. de Wit-van der Veen, Harshad R. Kulkarni, Aviral Singh, Marcel P.M. Stokkel and Richard P. Baum

Journal of Nuclear Medicine September 2019, 60 (9) 1259-1265; DOI: https://doi.org/10.2967/jnumed.118.224386

Else A. Aalbersberg

1Department of Nuclear Medicine, ENETS Centre of Excellence, Netherlands Cancer Institute, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daphne M.V. Huizing

1Department of Nuclear Medicine, ENETS Centre of Excellence, Netherlands Cancer Institute, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Iris Walraven

2Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Berlinda J. de Wit-van der Veen

1Department of Nuclear Medicine, ENETS Centre of Excellence, Netherlands Cancer Institute, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Harshad R. Kulkarni

3Theranostics Centre for Molecular Radiotherapy and Precision Oncology, ENETS Centre of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Aviral Singh

3Theranostics Centre for Molecular Radiotherapy and Precision Oncology, ENETS Centre of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany; and

4GROW–School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcel P.M. Stokkel

1Department of Nuclear Medicine, ENETS Centre of Excellence, Netherlands Cancer Institute, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Richard P. Baum

3Theranostics Centre for Molecular Radiotherapy and Precision Oncology, ENETS Centre of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 60, Issue 9

September 1, 2019

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients

Else A. Aalbersberg, Daphne M.V. Huizing, Iris Walraven, Berlinda J. de Wit-van der Veen, Harshad R. Kulkarni, Aviral Singh, Marcel P.M. Stokkel, Richard P. Baum

Journal of Nuclear Medicine Sep 2019, 60 (9) 1259-1265; DOI: 10.2967/jnumed.118.224386

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients

Else A. Aalbersberg, Daphne M.V. Huizing, Iris Walraven, Berlinda J. de Wit-van der Veen, Harshad R. Kulkarni, Aviral Singh, Marcel P.M. Stokkel, Richard P. Baum

Journal of Nuclear Medicine Sep 2019, 60 (9) 1259-1265; DOI: 10.2967/jnumed.118.224386

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Theranostics

Can ¹⁷⁷Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
Determination of the Intralesional Distribution of Theranostic ¹²⁴I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
Evidence-Based Clinical Protocols to Monitor Efficacy of [¹⁷⁷Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data

Show more Theranostics

Clinical

Tau^IQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
Addition of ¹³¹I-MIBG to PRRT (⁹⁰Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors

Show more Clinical

Keywords

PRRT
neuroendocrine tumor
multivariate analysis

Main menu

User menu

Search

Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Theranostics

Clinical

Similar Articles

Keywords